Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) reported Other Non-Current Assets of $7.1 million for Q4 2025, up 172.63% year-over-year from $2.6 million in Q4 2024, and up 199.44% quarter-over-quarter from $2.4 million in Q2 2025.

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has 3 years of Other Non-Current Assets data on file, last reported at $7.1 million in Q4 2025.

  • Other Non-Current Assets for Q4 2025 came in at $7.1 million, up 172.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.1 million (up 172.63% YoY), and the FY2025 annual result was $1.0 million, down 9.07% from the prior year.
  • Other Non-Current Assets grew to $7.1 million in Q4 2025 per ZYBT's latest filing, from $2.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $7.1 million in Q4 2025 and troughed at $624576.6 in Q4 2023.
  • A 3-year average of $3.2 million and a median of $2.5 million in 2024 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 316.77% in 2024, then soared 172.63% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $624576.6 in 2023, then surged by 316.77% to $2.6 million in 2024, then soared by 172.63% to $7.1 million in 2025.
  • Business Quant data shows ZYBT's Other Non-Current Assets at $7.1 million in Q4 2025, $2.4 million in Q2 2025, and $2.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Zhengye Biotechnology Holding 5.49 Mn 6.20 Mn - 7.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.10 Mn
Jun 30, 2025 2.37 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2023 624,576.61